Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2298)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.37
Total Value
$352.88K
Shares Held After
40,513
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$550.40
Total Value
$357.76K
Shares Held After
41,153
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
948
Price
$549.58
Total Value
$521.01K
Shares Held After
41,803
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,144
Price
$547.93
Total Value
$1.17M
Shares Held After
42,751
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.07
Total Value
$834.28K
Shares Held After
44,895
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,131
Price
$546.13
Total Value
$1.16M
Shares Held After
46,420
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,462
Price
$544.89
Total Value
$796.63K
Shares Held After
48,551
% of Holdings
2.9%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
524
Price
$2.11
Total Value
$1.11K
Shares Held After
514,903
% of Holdings
0.1%
SERA PROGNOSTICS, INC. (SERA)
Lawrence Sandra AJ — Director
Shares
1,560
Price
$2.15
Total Value
$3.35K
Shares Held After
16,473
% of Holdings
8.7%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
249
Price
$2.11
Total Value
$525.64
Shares Held After
506,748
% of Holdings
0.0%
MYRIAD GENETICS INC (MYGN)
Kumar Rashmi — Director
Shares
15,000
Price
$4.46
Total Value
$66.84K
Shares Held After
171,889
% of Holdings
8.0%
Medtronic plc (MDT)
KIIL HARRY SKIP — EVP & President Cardiovascular
Shares
228
Price
$80.45
Total Value
$18.34K
Shares Held After
37,227
% of Holdings
0.6%
Medtronic plc (MDT)
KIIL HARRY SKIP — EVP & President Cardiovascular
Shares
3,961
Price
$80.44
Total Value
$318.62K
Shares Held After
37,455
% of Holdings
9.6%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
2,261,118
Price
$0.11
Total Value
$239.68K
Shares Held After
2,647,299
% of Holdings
85.4%
RESMED INC (RMD)
Farrell Michael J. — Director
Shares
4,991
Price
$193.96
Total Value
$968.06K
Shares Held After
466,256
% of Holdings
1.1%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
5,222
Price
$27.30
Total Value
$142.56K
Shares Held After
139,763
% of Holdings
3.6%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
2,400
Price
$1.12
Total Value
$2.69K
Shares Held After
133,325
% of Holdings
1.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
60,547
Price
$0.40
Total Value
$24.22K
Shares Held After
377,211
% of Holdings
13.8%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
5,045
Price
$1.57
Total Value
$7.92K
Shares Held After
69,553
% of Holdings
7.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
49,966
Price
$1.57
Total Value
$78.45K
Shares Held After
688,926
% of Holdings
7.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
2,884
Price
$1.30
Total Value
$3.75K
Shares Held After
208,491
% of Holdings
1.4%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — General Counsel, Compliance Officer and Corporate Secretary
Shares
558
Price
$1.30
Total Value
$724.84
Shares Held After
126,491
% of Holdings
0.4%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
3,737
Price
$1.30
Total Value
$4.85K
Shares Held After
377,533
% of Holdings
1.0%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
116
Price
$218.81
Total Value
$25.38K
Shares Held After
6,183
% of Holdings
1.8%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
3,174
Price
$218.11
Total Value
$692.28K
Shares Held After
6,299
% of Holdings
33.5%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
4,694
Price
$217.30
Total Value
$1.02M
Shares Held After
9,473
% of Holdings
33.1%
Natera, Inc. (NTRA)
Marcus Gail Boxer — Director
Shares
3,016
Price
$216.06
Total Value
$651.65K
Shares Held After
14,167
% of Holdings
17.6%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP & CFO
Shares
3,312
Price
$80.00
Total Value
$264.96K
Shares Held After
180,393
% of Holdings
1.8%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$19.27
Total Value
$19.27K
Shares Held After
43,415
% of Holdings
2.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
3,500
Price
$19.46
Total Value
$68.11K
Shares Held After
42,415
% of Holdings
8.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
6,000
Price
$19.48
Total Value
$116.88K
Shares Held After
38,915
% of Holdings
15.4%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
10,000
Price
$19.41
Total Value
$194.10K
Shares Held After
32,915
% of Holdings
23.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
500
Price
$19.44
Total Value
$9.72K
Shares Held After
42,915
% of Holdings
1.2%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
1,843
Price
$167.31
Total Value
$308.36K
Shares Held After
15,860
% of Holdings
10.4%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
5,829
Price
$166.56
Total Value
$970.86K
Shares Held After
17,703
% of Holdings
24.8%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
6,896
Price
$165.79
Total Value
$1.14M
Shares Held After
23,532
% of Holdings
22.7%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
2,549
Price
$164.44
Total Value
$419.16K
Shares Held After
30,428
% of Holdings
7.7%
NEUROCRINE BIOSCIENCES INC (NBIX)
SHERWIN STEPHEN A — Director
Shares
7,883
Price
$163.81
Total Value
$1.29M
Shares Held After
32,977
% of Holdings
19.3%
Butterfly Network, Inc. (BFLY)
Cashman Steve — Chief Business Officer
Shares
104,781
Price
$4.96
Total Value
$520.13K
Shares Held After
1,925,087
% of Holdings
5.2%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
354
Price
$35.82
Total Value
$12.68K
Shares Held After
51,884
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
1,867
Price
$35.36
Total Value
$66.01K
Shares Held After
52,238
% of Holdings
3.5%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
7,779
Price
$34.28
Total Value
$266.66K
Shares Held After
54,105
% of Holdings
12.6%
GLOBUS MEDICAL INC (GMED)
Davidar David D — Director
Shares
25,000
Price
$80.76
Total Value
$2.02M
Shares Held After
510,175
% of Holdings
4.7%
MYOMO, INC. (MYO)
KIRK THOMAS F — Director
Shares
40,002
Price
$1.27
Total Value
$50.80K
Shares Held After
693,865
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,745
Price
$450.00
Total Value
$785.25K
Shares Held After
21,015
% of Holdings
7.7%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
2
Price
$167.88
Total Value
$335.76
Shares Held After
21,259
% of Holdings
0.0%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
39
Price
$164.82
Total Value
$6.43K
Shares Held After
21,261
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
78
Price
$163.36
Total Value
$12.74K
Shares Held After
21,300
% of Holdings
0.4%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
374
Price
$162.78
Total Value
$60.88K
Shares Held After
21,378
% of Holdings
1.7%
ILLUMINA, INC. (ILMN)
Leckman Patricia — SVP, Chief People Officer
Shares
290
Price
$161.79
Total Value
$46.92K
Shares Held After
21,752
% of Holdings
1.3%
Showing 1651–1700 of 2298 transactions (page 34 of 46)